Literature DB >> 22761229

Progression of coronary disease in a Behcet's patient in remission.

Anil Abeyewickreme1, Anil Ramoutar, Alamgir Kabir.   

Abstract

Behcet's disease is characterised histologically by vasculitis. In the heart this can lead to aneurysm formation and thrombosis. There is also accelerated atherosclerosis, the mechanism of which is unclear. Patients with external disease from Behcet's disease are treated with immunosuppression. The authors present a case of aneurysmal disease in a Behcet's patient. This case demonstrates that coronary disease may progress in Behcet's patients despite external disease remission. Therefore, internal disease may progress in the absence of external symptoms when immunosuppressive therapy is usually stopped. This case raises the issue of whether immunosuppression should be continued in Behcet's patients with coronary disease to suppress disease progression or included in a treatment protocol for patients with Behcet's related coronary disease. Clinical trials on the use of immunosuppressive therapy for coronary disease in Behcet's patients are needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761229      PMCID: PMC3391404          DOI: 10.1136/bcr.03.2012.6151

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Vascular Behçet's disease with coronary artery aneurysm.

Authors:  Kumiko Arishiro; Jin Nariyama; Masaaki Hoshiga; Atushi Nakagawa; Taichi Okabe; Takahiro Nakakoji; Nobuyuki Negoro; Tadashi Ishihara; Toshiaki Hanafusa
Journal:  Intern Med       Date:  2006-09-01       Impact factor: 1.271

Review 2.  Treatment strategies for Behçet's disease.

Authors:  Izzet Fresko; Hasan Yazici
Journal:  Expert Opin Pharmacother       Date:  2008-12       Impact factor: 3.889

3.  Acute myocardial infarction and ascending aortic aneurysm in a child with Behçet's disease.

Authors:  Jian Zhuang; Shushui Wang; Zhiwei Zhang; Shaoying Zeng; Yunzhen Shi; Shaohan Nong
Journal:  Turk J Pediatr       Date:  2008 Jan-Feb       Impact factor: 0.552

Review 4.  The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases.

Authors:  Armen Yuri Gasparyan; Antonios Stavropoulos-Kalinoglou; Dimitri P Mikhailidis; Tracey E Toms; Karen M J Douglas; George D Kitas
Journal:  Curr Vasc Pharmacol       Date:  2010-07       Impact factor: 2.719

5.  Behçet's Disease: an Insight from a Cardiologist's Point of View.

Authors:  Giuseppe Cocco; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

6.  [A case of aneurysmal dilatation of a saphenous vein graft for subclavian aneurysm in a patient with Behçet disease].

Authors:  A Yanagiya; T Kazui; K Nakanishi; O Yamada; T Sasaki; S Komatsu
Journal:  Nihon Geka Gakkai Zasshi       Date:  1987-07

7.  Arterial lesions in Behçet's disease. A study in 25 patients.

Authors:  D Lê Thi Huong; B Wechsler; T Papo; J C Piette; O Bletry; J M Vitoux; E Kieffer; P Godeau
Journal:  J Rheumatol       Date:  1995-11       Impact factor: 4.666

8.  A case of Behçet's disease with pericarditis, thrombotic thrombocytopenic purpura, deep vein thrombosis and coronary artery pseudo aneurysm.

Authors:  Chang Mo Kwon; Seung Hyun Lee; Jin Ho Kim; Kyu Hyung Lee; Hyun Do Kim; Yeong Hoon Hong; Choong Ki Lee
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

9.  Stenosis and aneurysm of coronary arteries in a patient with Behçet's Disease.

Authors:  Hammami Sonia; Ben Hamda Khaldoun; Mahjoub Sylvia; Maatoug Faouzi; Gamra Habib; Ben Farhat Mohamed
Journal:  Open Cardiovasc Med J       Date:  2008-12-19
  9 in total
  1 in total

1.  Recurrent Myocardial Infarction Despite Normal C-reactive Protein in a Patient with Behcet's Disease and Compound Heterozygous Methylenetetrahydrofolate Reductase (MTHFR) Mutations (C677T and A1298C).

Authors:  Muhammad Hamza Saad Shaukat; Aixa Toledo-Garcia; Mikhail Torosoff
Journal:  Cureus       Date:  2019-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.